Maximum quantity allowed is 999
Please select the quantity
CAS RN: 77671-31-9 | Product Number: E1370
Enoximone
×
![]()
×
Purity: >95.0%(HPLC)
Synonyms:
- 4-Methyl-5-[4-(methylthio)benzoyl]-1,3-dihydro-2H-imidazol-2-one
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
|
|---|---|---|---|---|---|
| 10MG |
₩427,400
|
18 | 0 | It can be shipped in about 3-4 weeks after ordering | |
| 50MG |
₩1,224,700
|
20 | 0 | It can be shipped in about 3-4 weeks after ordering |
* Please contact our distributor of SEJIN CI Co., Ltd.
if you would like to purchase TCI products. The above prices do not include freight cost, customs charge and other charges to the destination. SEJIN CI Co., Ltd. (Phone: 02-2655-2480 / email:
sales@sejinci.co.kr)
* The storage conditions are subject to change without notice.
* The storage conditions are subject to change without notice.
| Product Number | E1370 |
| Purity / Analysis Method | >95.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__1__2H__1__2N__2O__2S = 248.30 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Air Sensitive |
| CAS RN | 77671-31-9 |
| Reaxys Registry Number | 5036229 |
| PubChem Substance ID | 468591738 |
| MDL Number | MFCD00867130 |
Specifications
| Appearance | Light yellow to Brown powder to crystal |
| Purity(HPLC) | min. 95.0 area% |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 270 °C |
GHS
Related Laws:
| RTECS# | NI8026700 |
Transport Information:
| H.S.code* | 2933.29-000 |
Application
Enoximone: A Selective Inhibitor of the Phosphodiesterase-III (PDE-III)
Enoximone (MDL 17043), an imidazolone derivative, is a selective inhibitor of the phosphodiesterase-III enzyme (PDE-III) and possesses positive inotropic and vasodilatory properties, and is active by both oral and intravenous routes of administration.
References
- Characterization of the cardiovascular activities of a new cardiotonic agent, MDL 17043 (1,3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one)
- Biotransformation and pharmacokinetic overview of enoximone and its sulfoxide metabolite (a review)
- Enoximone. A review of its pharmacological properties and therapeutic potential
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.